PLACENTA ACCRETA SPECTRUM DISORDERS
DOI:
https://doi.org/10.22159/ajpcr.2023v16i9.47303Keywords:
Cesarean hysterectomy, Placenta accreta, Placenta increta, Placenta percretaAbstract
Placenta accreta spectrum is a rare pathology, but there is an increase in the incidence of placenta accreta. In the accreta spectrum, abnormal placental adherence to the myometrium stems in part from partial or total absence of the decidua basalis and imperfect development of the fibrinoid or Nitabuch layer. This results in the absence of a physiological line of cleavage, so resulting in failure of separation of the placenta causing significant hemorrhage. This leads to maternal morbidity and mortality. 12 patients of placenta accreta managed at Government Medical College and Rajindra Hospital, Patiala, over 1 year (December 2021–November 2022) were reported. All cases had a histopathologically proven diagnosis of placenta accreta. The major risk factors identified were placenta previa, previous cesarean section, multiparity, advanced maternal age, previous uterine surgeries, or curettage. Ultrasound (USG) color Doppler and magnetic resonance imaging allowed us to strongly suspect the presence of placenta accreta in a pregnant woman with risk factors. Placenta accreta spectrum is associated with life-threatening hemorrhage, urinary bladder injury, intensive care unit admission, massive blood transfusion, and maternal death. The course of action in each and every patient varies according to whether the diagnosis of the placenta is made antenatal or during C-section and the amount of blood loss.
Downloads
References
Jauniaux E, Ayres-de-Campos D, FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction. Int J Gynaecol Obstet 2018;140:261-4. doi: 10.1002/ijgo.12406, PMID 29405322
Wong HS, Hutton J, Zuccollo J, Tait J, Pringle KC. The maternal out come in placenta accreta the significance of antenatal diagnosis and non-separation of placenta at delivery. N Z Med J 2008;121:30-8.
Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: Twenty-year analysis. Am J Obstet Gynecol 2005;192:1458-61. doi: 10.1016/j. ajog.2004.12.074, PMID 15902137
Duzyj CM, Buhimschi IA, Motawea H, Laky CA, Cozzini G, Zhao G, et al. The invasive phenotype of placenta accreta extra villous trophoblasts associates with loss of E-cadherin. Placenta 2015;36:645- 51. doi: 10.1016/j.placenta.2015.04.001
Clouqueur E, Rubod C, Paquin A, Devisme L, Deruelle P. Placenta accreta: Diagnosis and management in a French Type-3 maternity hospital. J Gynecol Obstet Biol Reprod (Paris) 2008;37:499-504. doi: 10.1016/j.jgyn.2007.11.028, PMID 18178018
Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after Cesarean delivery: A systematic review and meta-analysis. Am J Obstet Gynecol 2017;217:27-36. doi: 10.1016/j. ajog.2017.02.050, PMID 28268196
Héquet D, Ricbourg A, Sebbag D, Rossignol M, Lubrano S, Barranger E. Placenta accreta: Depistage, prise en charge et complications. Gynecol Obstet Fertil 2013;41:31-7. doi: 10.1016/j.gyobfe.2012.11.001, PMID 23291052
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: A WHO systematic analysis. Lancet Glob Health 2014;2:e323-33. doi: 10.1016/S2214-109X(14)70227-X, PMID 25103301
Bailit JL, Grobman WA, Rice MM, Reddy UM, Wapner RJ, Varner MW, et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol 2015;125:683-9. doi: 10.1097/AOG.0000000000000680, PMID 25730233
Mehrabadi A, Hutcheon JA, Liu S, Bartholomew S, Kramer MS, Liston RM, et al. Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage. Obstet Gynecol 2015;125:814-21. doi: 10.1097/AOG.0000000000000722, PMID 25751202
Farquhar CM, Li Z, Lensen S, McLintock C, Pollock W, Peek MJ, et al. Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand: A case-control study. BMJ Open 2017;7:e017713. doi: 10.1136/bmjopen-2017-017713, PMID 28982832
Jing L, Wei G, Mengfan S, Yanyan H. Effect of site of placentation on pregnancy outcomes in patients with placenta previa. PLoS One 2018;13:e0200252. doi: 10.1371/journal.pone.0200252, PMID 30016336
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta, increta, percreta in the UK: A national case control study. PLoS One 2012;7:e52893. doi: 10.1371/journal.pone.0052893, PMID 23300807
Marshall NE, Fu R, Guise J. Impact of multiple caesaren deliverieson maternal morbidity: A systematic review. Am J Obstet Gynecol 2011;205:262.e1-8. doi: 10.1016/j.ajog.2011.06.035
Garmi G, Salim R. Epidemiology, etiology, diagnosis and management of placenta accreta. Obstet Gynecol Int 2012;2012:873929. doi: 10.1155/2012/873929, PMID 22645616
D’Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: Systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013;42:509-17. doi: 10.1002/uog.13194, PMID 23943408
Einerson BD, Rodriguez CE, Kennedy AM, Woodward PJ, DonnellyMA, Silver RM. Magnetic resonance imaging is often misleading when used as adjunct to ultrasound in the management of placenta accreta spectrum
disorders. Am J Obstet Gynecol 2018;218:618.e1-7.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Shelly Khillan, Parneet Kaur, Dr. Beant Singh
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
